Related by context. All words. (Click for frequent words.) 73 relapsing remitting MS 69 generalized seizures 67 generalized epilepsy 66 basal cell nevus syndrome 66 Relapsing remitting MS 66 proliferative diabetic retinopathy 66 myelodysplastic syndrome MDS 66 PAOD 66 AGILECT R 66 relapsing remitting multiple sclerosis 66 homozygous familial hypercholesterolemia 65 geographic atrophy 65 HBeAg negative 65 recurrent glioblastoma multiforme 65 leukemia AML 64 PsA 64 indolent NHL 64 osteosarcomas 64 lupus nephritis 63 mycosis fungoides 63 ADPKD 63 hematologic toxicity 63 stage IIIB 63 Follicular lymphoma 63 squamous 63 TEAEs 63 generalized tonic clonic seizures 63 relapsing forms 63 systemic lupus erythematosus 63 relapsing MS 63 proliferative retinopathy 63 Wegener granulomatosis 63 anterior uveitis 63 levodopa therapy 63 Chronic lymphocytic leukemia 63 choroidal neovascularization 63 ALT flares 63 neovascular AMD 63 Relapsing remitting 62 SJIA 62 neurological manifestations 62 MGUS 62 glioblastoma multiforme GBM 62 basal cell carcinomas 62 demyelinating 62 nonmelanoma skin cancers 62 DMARD 62 Aortic stenosis 62 basal cell carcinoma BCC 62 recurrent glioblastoma 62 systemic lupus erythematosus SLE 62 IBS C 62 heterozygous FH 62 dirucotide 62 metastatic malignant melanoma 62 carcinoid 62 pulmonary hypertension PH 62 Neovascular AMD 62 gastrointestinal stromal tumor 62 recurrent genital herpes 62 vWD 62 hepatitis C genotype 62 Plaque psoriasis 62 cytogenetic responses 62 T2DM 62 neurologic symptoms 62 essential thrombocythemia 62 acute myelogenous leukemia AML 61 1 diabetes T1D 61 candidemia 61 Glioblastoma Multiforme 61 common hematologic malignancy 61 autoantibody positive 61 leukemia ALL 61 squamous cell carcinoma SCC 61 metastatic renal cell carcinoma 61 metastatic RCC 61 juvenile idiopathic arthritis JIA 61 GISTs 61 intravenous bisphosphonates 61 immunomodulatory therapy 61 tocilizumab 61 INCB# [003] 61 relapsed MM 61 fungoides 61 ANCA associated 61 Ankylosing spondylitis 61 daunorubicin 61 inherited retinal degeneration 61 acute leukemias 61 grade cervical intraepithelial 61 bendamustine 61 plaque psoriasis 61 choroidal neovascularization CNV 61 heavily pretreated 61 Glioblastoma multiforme GBM 61 Sjögren syndrome 61 KRAS wild 61 follicular lymphoma FL 61 Toxicities 61 macular edema 61 Follicular Lymphoma 61 thymoma 61 neovascular 61 frontotemporal dementia 61 gastrointestinal stromal tumor GIST 61 myeloproliferative neoplasms 60 Glioblastoma 60 Natalizumab 60 carcinoid tumors 60 Alemtuzumab 60 eosinophilic asthma 60 colorectal liver metastases 60 hypercalcemia 60 diabetes mellitus DM 60 natalizumab 60 neuroendocrine cancers 60 familial ALS 60 anemia neutropenia 60 alemtuzumab treated 60 lysosomal storage disease 60 idarubicin 60 esophagitis 60 MELAS 60 adalimumab 60 fingolimod 60 hepatocellular carcinomas 60 PD LID 60 EDSS scores 60 lymphocytic leukemia 60 DMARDs 60 infantile onset 60 IV NSCLC 60 systemic corticosteroid 60 lupus erythematosus 60 chlorambucil 60 Lennox Gastaut syndrome 60 primary generalized tonic 60 Venous thromboembolism 60 leukemia CLL 60 polyarticular 60 DMARD therapy 60 pleural mesothelioma 60 paroxysmal AF 60 CIDP 60 postherpetic neuralgia 60 Thrombocytopenia 60 chronic HCV infection 60 posterior uveitis 60 differentiated thyroid 60 myelodysplastic syndromes 60 cytologically confirmed 60 onset seizures 60 basal cell cancers 60 baminercept 60 cell lymphoma CTCL 60 laboratory abnormalities 60 efalizumab 60 retinal vein occlusion 60 hepatocellular carcinoma 60 myelofibrosis 60 CMV disease 60 CIN3 60 histologically confirmed 60 taxane chemotherapy 60 cabazitaxel 60 non squamous NSCLC 60 juvenile idiopathic arthritis 60 Wilms tumor 60 Acute lymphoblastic leukemia 60 gastrointestinal toxicity 60 unresectable 60 HeFH 60 ethambutol 60 immunodeficiency 60 herpes zoster shingles 60 CHOP chemotherapy 60 dirucotide MBP# 60 immune thrombocytopenic purpura ITP 60 LHRH agonists 60 visilizumab 60 epithelial tumors 60 acute GvHD 60 macroalbuminuria 60 nonsmall cell lung cancer 60 immune thrombocytopenic purpura 60 heavily pretreated patients 60 myelosuppression 60 overt nephropathy 60 RRMS patients 59 brain metastases 59 neuro degenerative disease 59 Myelodysplastic Syndrome MDS 59 optic neuropathy 59 myoclonic seizures 59 invasive candidiasis 59 malignant pleural mesothelioma 59 cutaneous squamous cell carcinoma 59 superficial bladder cancer 59 myeloproliferative diseases 59 rosuvastatin #mg 59 Synovial sarcoma 59 imatinib resistant 59 myelodysplastic syndrome 59 progressive neurodegenerative disorder 59 polyneuropathy 59 chronic GVHD 59 synovial sarcoma 59 pheochromocytoma 59 fulminant 59 epithelioid 59 diarrhea predominant IBS 59 ankylosing spondylitis AS 59 sarcomas 59 Acute Myelogenous Leukemia AML 59 Gleevec resistant 59 cisplatin chemotherapy 59 hepatocellular carcinoma HCC 59 Diabetic neuropathy 59 RRMS 59 teriflunomide 59 chronic plaque psoriasis 59 FOLPI regimen 59 HBeAg positive 59 refractory AML 59 nephrotic syndrome 59 chronic myelogenous leukemia CML 59 Angioedema 59 intractable epilepsy 59 bullous 59 pemphigus vulgaris 59 Gorlin syndrome 59 lichen planus 59 tolvaptan 59 AGILECT ® 59 Hurthle cell 59 Basal cell carcinoma 59 euthymic patients 59 grade gliomas 59 arthritis RA 59 neoplasm 59 hypereosinophilic syndrome 59 familial amyloidotic polyneuropathy FAP 59 TTR amyloidosis 59 PCNSL 59 relapsing multiple sclerosis 59 sulfasalazine 59 Psoriatic arthritis 59 dengue hemorrhagic fever DHF 59 malignant neoplasm 59 histologic subtype 59 astrocytomas 59 demyelination 59 unfavorable cytogenetics 59 PEGylated interferon beta 1a 59 intermittent claudication 59 Etanercept 59 nonmelanoma skin cancer 59 debilitating autoimmune 59 blastic phase 59 anakinra 59 purpura 59 KRAS mutations occur 59 hypersensitivity reaction 59 Bacterial conjunctivitis 59 Traficet EN 59 lung cancer NSCLC 59 decitabine 59 post thrombotic syndrome 59 post herpetic neuralgia 59 acute myeloid leukemia AML 59 Chronic lymphocytic leukemia CLL 59 dopaminergic therapy 59 Wet AMD 59 Leber congenital amaurosis LCA 59 astrocytoma 59 Chronic HCV 59 hematological malignancy 59 APTIVUS r 59 nonalcoholic steatohepatitis NASH 59 complete remissions 59 complement inhibitor eculizumab 59 thromboembolic events 59 lymphocytic 59 anemias 59 Critical limb ischemia 59 chronic lymphocytic leukemia CLL 59 moderate renal impairment 59 MCyR 59 CTEPH 59 leukoencephalopathy 59 metastatic renal cell 59 gastrointestinal stromal tumors 59 neurologic disorder 59 lymphopenia 59 Pancreatic neuroendocrine tumors 59 LHON 59 Myelodysplastic Syndrome 59 EXJADE 59 cholinesterase inhibitor 59 AA Amyloidosis 59 Atopic dermatitis 59 acne vulgaris 59 interferon therapy 59 myelofibrosis polycythemia vera 59 axonal damage 59 squamous cell cancers 59 dysmotility 59 Acute myeloid leukemia 59 Chronic sinusitis 59 Ulcerative colitis 59 metastatic malignant 59 Hashimoto thyroiditis 59 alveolar rhabdomyosarcoma 59 Cutaneous T 59 relapsed SCLC 59 hemolytic anemia 59 histologies 59 Basal cell 58 thyrotoxicosis 58 myoclonus 58 uveitis 58 mcg albinterferon alfa 2b 58 MALT lymphoma 58 CIMZIA ™ 58 Sezary syndrome 58 Teriflunomide 58 primidone 58 Myelofibrosis 58 immunocompetent 58 follicular lymphomas 58 breast carcinomas 58 FTLD 58 completely resected 58 HER2 overexpression 58 receptor tyrosine kinase inhibitor 58 Osteosarcoma 58 ponatinib 58 hyperalgesia 58 duodenal ulcer 58 squamous histology 58 etanercept 58 secondary hyperparathyroidism 58 medullary thyroid cancer 58 liver metastases 58 elevated triglyceride levels 58 transaminase elevations 58 Chronic myeloid leukemia 58 diabetic gastroparesis 58 malignant fibrous histiocytoma 58 mitoxantrone 58 rheumatic disease 58 Rheumatoid arthritis 58 glomerulonephritis 58 Hepatocellular Carcinoma HCC 58 Fingolimod 58 CYT# potent vascular disrupting 58 intestinal metaplasia 58 refractory gout 58 interferon alfa 2b 58 lymphocytosis 58 subsyndromal 58 rheumatoid arthritis psoriatic arthritis 58 biologic DMARD 58 Gleevec imatinib mesylate 58 diabetic kidney 58 common disabling neurological 58 chronic myeloid 58 Cholangiocarcinoma 58 chronic eosinophilic leukemia 58 C1 INH deficiency 58 Herpes zoster 58 MPGN 58 infliximab Remicade 58 neurosyphilis 58 Eisenmenger syndrome 58 8mg/kg 58 chemotherapeutic regimens 58 interferon beta therapy 58 ara C 58 ischemic strokes 58 Dasatinib 58 idiopathic thrombocytopenic purpura ITP 58 renal cell carcinoma 58 Idiopathic pulmonary fibrosis 58 adriamycin 58 hepatic metastases 58 sporadic ALS 58 Pegasys ® 58 HAART regimen 58 haematologic 58 Neuropathic pain 58 dizziness imbalance 58 pancreatic NET 58 Retinitis Pigmentosa RP 58 multiple sclerosis SPMS 58 methotrexate MTX 58 infarcts 58 nasopharyngeal carcinoma 58 systemic autoimmune 58 hypophosphatemia 58 refractory multiple myeloma 58 remitting MS 58 graft dysfunction 58 Myasthenia gravis 58 MIRAPEX 58 diabetes mellitus T2DM 58 varices 58 Acute Myeloid Leukaemia AML 58 non hematological toxicities 58 Metastatic breast cancer 58 idiopathic Parkinson disease 58 non alcoholic steatohepatitis 58 erythematosus 58 Hurler syndrome 58 idiopathic pulmonary fibrosis IPF 58 HNSCC 58 riociguat 58 pathologic myopia 58 Glioma 58 CIMZIA TM 58 fatal neurodegenerative 58 polyneuropathy CIDP 58 Peripheral neuropathy 58 Peripheral arterial disease 58 Glioblastomas 58 hepatocellular cancer 58 smoldering myeloma 58 Bortezomib 58 atopic dermatitis AD 58 somatostatin analogs 58 Glioblastoma multiforme 58 cholangiocarcinoma 58 Castration Resistant Prostate Cancer 58 corticosteroid therapy 58 plus methotrexate 58 psoriatic arthritis PsA 58 curative resection 58 recurrent VTE 58 virological failure 58 Carcinoid tumors 58 open angle glaucoma 58 relapsing remitting MS RRMS 58 gouty arthritis 58 autosomal dominant 58 Sjogren syndrome 58 refractory NSCLC 58 pazopanib 58 Laquinimod 58 ACTEMRA TM 58 Non Hodgkin lymphoma 58 untreated celiac disease 58 Glioblastoma Multiforme GBM 58 FluCAM 58 FOLFIRI 58 granulomatous 58 cerebral vasospasm 58 myelodysplasia 58 paraganglioma 58 brain lesions 58 squamous cell 58 aHUS 58 mycophenolate mofetil 58 CRVO 57 nonalcoholic steatohepatitis 57 Atopic eczema 57 pomalidomide 57 renal tumors 57 Parkinsonian Syndromes 57 indolent lymphoma 57 scleroderma 57 motor neuron degeneration 57 experimental autoimmune encephalomyelitis 57 discoid lupus 57 peripheral sensory neuropathy 57 fibromyalgia syndrome 57 recurrent NSCLC 57 systemic juvenile idiopathic 57 extrapyramidal symptoms 57 hemorrhagic strokes 57 adrenal insufficiency 57 colorectal adenoma 57 cytogenetic response 57 Crohn disease CD 57 idiopathic 57 lung metastases 57 indolent lymphomas 57 recurrent seizures 57 AA amyloidosis 57 papillary renal cell carcinoma 57 gastrointestinal perforation 57 nonischemic 57 anaplastic astrocytoma AA 57 gout flares 57 chronic myeloid leukemia CML 57 cutaneous lesions 57 ocrelizumab 57 cutaneous T cell 57 relapsed Acute Myeloid 57 pericardial effusions 57 Malignant mesothelioma 57 metastatic bladder 57 fatal neuromuscular disorder 57 neurodegenerative disorder 57 relapsed refractory multiple myeloma 57 white matter hyperintensities 57 Chronic ITP 57 HER2 positive metastatic breast 57 anaplastic 57 seropositive patients 57 grade dysplasia 57 cytopenias 57 relapsed AML 57 torsade de pointes 57 germline mutation 57 Ribavirin causes 57 osteoarthritis rheumatoid arthritis 57 Systemic lupus 57 severe exacerbations 57 mucinous 57 evaluable subjects 57 tumor xenograft models 57 serous ovarian cancer 57 azathioprine 57 TMP SMX 57 pericardial effusion 57 subependymal giant cell 57 Pulmonary hypertension 57 conventional DMARDs 57 bone metastasis 57 metastatic lung cancer 57 VA# [002] 57 Non Alcoholic Steatohepatitis 57 aminotransferases 57 progressive multifocal leukoencephalopathy PML 57 orchitis 57 scaly patches 57 immunosuppressed patients 57 chemoradiotherapy 57 Haptoglobin 57 VFEND 57 Rheumatoid arthritis RA 57 neuroendocrine tumors 57 metastatic lesions 57 phase IIb clinical 57 metastatic colorectal carcinoma 57 candidiasis 57 juvenile myoclonic epilepsy 57 Raynaud phenomenon 57 immunodeficiencies 57 papules 57 proteasome inhibitor 57 allogeneic stem cell 57 K ras mutations 57 unprovoked seizures 57 VEGF inhibitors 57 intravitreal injections 57 carboplatin paclitaxel 57 T2 lesions 57 BRAF mutation 57 Hypotension 57 lymphoma CTCL 57 typical antipsychotics 57 optic neuritis 57 thalidomide Thalomid 57 amnestic mild cognitive impairment 57 symptomatic BPH 57 FOLFOX6 57 anticholinergics 57 minimally symptomatic 57 neuropsychiatric symptoms 57 idiopathic thrombocytopenic purpura 57 relapsed leukemia 57 Renal cell carcinoma 57 Juvenile Idiopathic Arthritis JIA 57 preoperative chemotherapy 57 myelofibrosis MF 57 cutaneous T 57 partial onset seizures 57 non metastatic osteosarcoma 57 low dose cytarabine 57 anaplastic astrocytoma 57 nonmetastatic 57 protease inhibitor PI 57 Papillary 57 allogeneic bone marrow 57 NOMID 57 Epratuzumab 57 allodynia 57 Naive Patients 57 von Willebrand disease 57 seminoma 57 idraparinux 57 cytogenetic abnormalities 57 clonic seizures 57 hematologic disorders 57 dosing cohort 57 demyelinating disease 57 pericardial mesothelioma 57 Genital herpes 57 severe malignant osteopetrosis 57 VaD 57 IGFD 57 oral vancomycin 57 unresectable stage 57 partial remissions 57 Squamous 57 neutropenia dehydration dyspnea 57 receiving VICTRELIS 57 active ankylosing spondylitis 57 thrombocytopenic patients 57 neuro invasive 57 revascularization procedures 57 peritumoral brain edema 57 tyrosine kinase inhibitors 57 SSc 57 pamidronate 57 DFMO 57 artery stenosis 57 soft tissue sarcomas 57 generalized edema 57 tumor shrinkage 57 malignant pheochromocytoma 57 basiliximab 57 chronic HBV infection 57 invasive fungal infection 57 enalapril 57 familial pancreatic cancer 57 steatohepatitis 57 interferon IFN 57 xerostomia 57 acute gout 57 chronic hepatitis cirrhosis 57 beta interferons 57 progressive PsA 57 GSK# [001] 57 follicular lymphoma 57 Systemic lupus erythematosus SLE 57 glatiramer acetate 57 intensive statin therapy 57 subarachnoid hemorrhage SAH 57 pilocytic astrocytoma 57 FOLPI 57 gastric carcinoma 57 anemia hemoglobin 57 peripheral neuropathy 57 COPAXONE ® 57 lymphomas 57 variable immunodeficiency 57 hepatorenal syndrome 57 carcinoid syndrome 57 cutaneous melanoma 57 severe neutropenia 57 infective endocarditis 57 diabetic nephropathy 57 abacavir Ziagen 57 hyperammonemia 57 T1DM 57 beta interferon 57 CsA 57 levodopa 57 Stargardt Macular Dystrophy 57 esophageal candidiasis 57 rheumatoid arthritis 57 alefacept 57 Chronic Myelogenous Leukemia CML 57 Myelodysplastic syndromes 57 amenorrhoea 57 NNRTIs 57 BARACLUDE ® 56 HCV infection 56 adenoma 56 parkinsonism 56 nucleoside analogs 56 myeloid 56 juvenile myelomonocytic leukemia 56 methimazole 56 IFN beta 56 Nonalcoholic fatty liver 56 primary Restless Legs 56 moderate plaque psoriasis 56 Pervasive Developmental Disorder 56 neuroblastomas 56 metastatic CRC 56 peritoneal cancer 56 ductal breast cancer 56 gastric atrophy 56 Pleural mesothelioma 56 neuronal ceroid lipofuscinosis NCL 56 phase IIb study 56 TKI therapy 56 tumor regressions 56 Relapses 56 retinal vein occlusion RVO 56 hematologic adverse 56 systemic scleroderma 56 erlotinib Tarceva ® 56 small lymphocytic lymphoma 56 INVEGA ® 56 weekly intravenous infusions 56 lymphoproliferative disorder 56 T#I mutant 56 2 diabetes T2D 56 Idiopathic pulmonary fibrosis IPF 56 COPAXONE R 56 polymyalgia rheumatica 56 delayed CINV 56 placebo dexamethasone 56 ALT elevations 56 resectable 56 post transplant lymphoproliferative 56 grade glioma 56 keloid 56 hypertrophic scars 56 Chronic pancreatitis 56 posaconazole 56 ependymoma 56 paresthesias 56 glioblastoma tumors 56 polyposis 56 calcineurin inhibitors 56 Endometrial cancer 56 homozygous FH 56 liver metastasis 56 Barrett esophagus BE 56 dexamethasone Decadron 56 Chronic Lymphocytic Leukemia CLL 56 biochemical relapse 56 leukopenia 56 lenalidomide Revlimid R 56 rFVIIa 56 Cimzia ® certolizumab pegol 56 lysosomal storage diseases 56 disease modifying antirheumatic 56 Parkinson disease PD 56 viral conjunctivitis 56 hepatic encephalopathy HE 56 Parkinson Disease PD 56 gastrointestinal stromal tumors GIST 56 INCB# [001] 56 onset diabetes mellitus 56 metastatic colon cancer 56 Velcade bortezomib 56 renal dysfunction 56 hepatic impairment 56 cell carcinoma 56 Inflammatory bowel disease 56 pegylated liposomal doxorubicin 56 standard chemotherapy regimens 56 ximelagatran 56 tonic clonic seizures 56 atypical Hemolytic Uremic Syndrome 56 nonmetastatic prostate cancer 56 diagnosed glioblastoma multiforme 56 AMN# [001] 56 pernicious anemia 56 sustained virologic response 56 ischemic colitis 56 Xanafide 56 rituximab Rituxan 56 malabsorptive 56 elevated ALT 56 IDH1 mutation 56 Torisel 56 primary hypercholesterolemia 56 EBV infection 56 carotid stenosis 56 non hodgkin lymphoma 56 subconjunctival hemorrhage 56 Fludarabine 56 alkylating agent 56 tigecycline 56 non Hodgkin lymphomas 56 advanced hepatocellular carcinoma 56 Levodopa 56 carcinoid cancer 56 lumiliximab 56 hepatic encephalopathy 56 Ischemic strokes 56 leukemia CML 56 CLL SLL 56 metastatic neuroendocrine tumors 56 sJIA 56 neurogenic orthostatic hypotension 56 dysthymia 56 BRAF inhibitor 56 Soft Tissue Sarcoma 56 cytoreduction 56 lacunar 56 IV metastatic melanoma 56 papillary 56 dysplastic lesions 56 cIAI 56 drug DMARD 56 Index CDAI 56 DLBCL 56 intracranial hemorrhage ICH 56 Retreatment 56 autoimmune thyroid 56 pediatric acute lymphoblastic 56 icatibant 56 actinic keratosis 56 ACTEMRA 56 SCIg 56 neovascular diseases 56 microvascular disease 56 Fibrillex TM 56 cell lymphoma ALCL 56 herpes zoster 56 arthritis PsA 56 leukemia APL 56 smoldering multiple myeloma 56 DLTs 56 FluCAM arm 56 invasive ductal breast cancer 56 cervical lesions 56 Alzheimer disease vascular dementia 56 paragangliomas 56 cytotoxic chemotherapy 56 superficial basal cell carcinoma 56 Restless Legs Syndrome RLS 56 EGFRIs 56 dose limiting toxicities 56 Doxil ® 56 NMIBC 56 extracranial 56 optic neuropathy NAION 56 rheumatoid arthritis Crohn disease 56 Adjuvant chemotherapy 56 chronic idiopathic 56 pseudotumor cerebri 56 virologic failure 56 sensory neuropathy 56 Testicular cancer 56 Chronic Myeloid Leukemia 56 neurofibromas 56 amnestic MCI 56 Enzastaurin 56 Irritable bowel syndrome 56 de novo AML 56 familial adenomatous polyposis 56 atypical hemolytic uremic syndrome 56 cortical dysplasia 56 SCCHN 56 malignant gliomas 56 biliary tract cancer 56 POAG 56 Peripheral edema 56 Riluzole 56 FAMPYRA 56 malignant lymphoma 56 invasive aspergillosis 56 Cladribine tablets 56 Osteoarthritis OA 56 Leukemias 56 interferon alfa 56 induce orthostatic hypotension 56 dyskeratosis congenita 56 adverse reactions ≥ 56 chemoradiation 56 squamous cell cancer 56 5-FU/LV 56 dysmenorrhoea 56 ano genital warts 56 vismodegib 56 Acute Bacterial Sinusitis ABS 56 epilepsies 56 stable angina 56 caspofungin 56 K#N 56 uric acid lowering 56 dermatologic reactions 56 MIRAPEX ER 56 chronic heartburn 56 inflammatory arthritis 56 receiving golimumab 56 Phenoptin 56 chronic granulomatous disease 56 cholinesterase inhibitors 56 dexpramipexole 56 Zolinza 56 Bronchiectasis 56 immunosuppressed 56 unknown etiology 56 medulloblastoma 56 red scaly patches 56 eosinophilic 56 antihypertensive therapy 56 adenocarcinomas 56 PTLD 56 refractory CTCL 56 TNF inhibitors 56 immunosuppressive agents 56 adenocarcinoma 56 mitoxantrone chemotherapy 56 Pulmonary arterial hypertension 56 chronic idiopathic thrombocytopenic purpura 56 Neovascular Age Related Macular 56 Acute Coronary Syndromes ACS 56 lipid lowering agents 56 atherothrombosis 56 Acute Myelogenous Leukemia 56 TNF blocker therapy 56 histologically proven 56 imatinib therapy 56 sirolimus 56 symptomatic paroxysmal AF 56 pleomorphic 56 Ph + ALL 56 alanine aminotransferase ALT 56 precancerous cervical lesions 56 MPS IVA 56 Relapsing 56 Rheumatoid Arthritis RA 56 metformin sulfonylurea 56 Adenocarcinoma 56 Henoch purpura 56 Chronic Prostatitis 56 seminomas 56 Crohn disease 56 interstitial pneumonia 56 neurologic deficits 56 mutated KRAS 56 dosing cohorts 56 lenalidomide dexamethasone 56 tricyclic antidepressants 56 GBM tumors 56 associated lymphoid tissue 56 canakinumab 56 interferon alfa 2a 56 NATRECOR R 56 intra articular injection 56 Leber congenital amaurosis 56 remyelination 56 mCRC patients 56 AAT deficiency 56 CP CPPS 56 GH deficiency 56 chronic periodontitis 56 paroxysmal 56 colorectal carcinoma 56 ARVD 56 tumors GIST 56 symptomatic aortic stenosis 56 transaminase levels 56 hypomagnesemia 56 Retinitis pigmentosa 56 severe renal impairment 56 NYHA Class II 56 Myotonic dystrophy 56 cytoreductive surgery 56 vitreous hemorrhage 56 dasatinib 56 endometrial hyperplasia 56 docetaxel chemotherapy 56 nephrotoxicity 56 cervical dysplasia 56 ribavirin RBV 56 NSCLC 56 Lung transplantation 56 myelodysplastic myeloproliferative diseases 56 stage IIIA 56 oral FTY# 56 dacarbazine 56 reactive arthritis 56 Philadelphia Chromosome Positive 56 Pharmacokinetics PK 56 proctitis 56 myasthenia gravis MG 56 inflammatory bowel diseases 56 hour bronchodilation 56 pancytopenia 56 TNF antagonist 56 metastatic GIST 56 metastatic tumors 56 romiplostim 56 ribavirin therapy 56 acute promyelocytic leukemia 56 abatacept 56 T#I mutation 56 doxorubicin cyclophosphamide 56 octreotide LAR 56 Candida infection 56 EDSS score 56 hepatic cirrhosis 56 macular disease 56 tumor recurrence 55 MBP# [001] 55 TACE 55 chorea 55 Scale EDSS 55 endothelin receptor antagonists 55 ER CHOP 55 biologic therapy 55 RSV infections 55 Sapacitabine 55 liver histology 55 lymphoma subtypes 55 serum HBV DNA